3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
15
Lymphoid
2
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Head and Neck Neoplasms
27
Squamous Cell Carcinoma of Head and Neck
14
Oropharyngeal Neoplasms
6
Carcinoma, Squamous Cell
6
Neoplasms
5
Lung Neoplasms
4
Thyroid Neoplasms
3
Nasopharyngeal Carcinoma
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Liver Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Epstein-Barr Virus Infections
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vitamin D Deficiency
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Tonsillar Neoplasms
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pneumothorax
1
Interventions
Nivolumab
4
regorafenib
2
pembrolizumab
2
Drug Therapy
2
Cisplatin
2
vocimagene amiretrorepvec
1
ulixertinib
1
spartalizumab
1
motexafin gadolinium
1
erythromycin propionate-N-acetylcysteinate
1
epacadostat
1
durvalumab
1
depatuxizumab mafodotin
1
cobimetinib
1
cc-486
1
aflibercept
1
Thalidomide
1
Tamoxifen
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
NEO212
1
Molecular Diagnostic Techniques
1
Ipilimumab
1
Injections
1
Immunotherapy
1
IFL protocol
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Blood Specimen Collection
×
Head & Neck
×
Clear all
NCT03787056
2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA
Recruiting
410 enrolled